Metabolic reprogramming and tolerance during sepsis-induced AKI

Nature Reviews Nephrology

Volumn 13, Issue 3, 2017, Pages 143-151

  Gómez, Hernando ^a   Kellum, John A ^a   Ronco, Claudio ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ADAPTATION; CELL DEATH; CHRONIC KIDNEY FAILURE; DISEASE RESISTANCE; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFLAMMATION; KIDNEY TUBULE CELL; KIDNEY TUBULE EPITHELIUM; METABOLIC REGULATION; METABOLIC REPROGRAMMING; METABOLISM; NONHUMAN; REVIEW; SEPSIS; SURVIVAL; TISSUE INJURY; WARBURG METABOLISM; ACUTE KIDNEY INJURY; ANIMAL; COMPLICATION; IMMUNOLOGICAL TOLERANCE; RENAL INSUFFICIENCY, CHRONIC;

ACUTE KIDNEY INJURY; ANIMALS; HUMANS; IMMUNE TOLERANCE; RENAL INSUFFICIENCY, CHRONIC; SEPSIS;

EID: 85009754391     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2016.186     Document Type: Review

References (80)

1. Schneider, D. S. &Ayres, J. S. Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases. Nat. Rev. Immunol. 8, 889-895 (2008)
2. Singer, M. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis 3). JAMA 315, 801-810 (2016)
3. Cheng, S.-C. et al. Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat. Immunol. 17, 406-413 (2016)
4. Hotchkiss, R. S., Monneret, G. &Payen, D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13, 862-874 (2013)
5. Cohen, J. et al. Sepsis: a roadmap for future research. Lancet Infect. Dis. 15, 581-614 (2015)
6. Figueiredo, N. et al. Anthracyclines induce DNA damage response-mediated protection against severe sepsis. Immunity 39, 874-884 (2013)
7. Zager, R. A. 'Biologic memory' in response to acute kidney injury: cytoresistance, toll-like receptor hyper-responsiveness and the onset of progressive renal disease. Nephrol. Dial. Transplant. 28, 1985-1993 (2013)
8. Uchino, S. et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294, 813-818 (2005)
9. Thakar, C. V., Yared, J. P., Worley, S., Cotman, K. &Paganini, E. P. Renal dysfunction and serious infections after open-heart surgery. Kidney Int. 64, 239-246 (2003)
10. Murugan, R. &Kellum, J. A. Acute kidney injury: what's the prognosis? Nat. Rev. Nephrol. 7, 209-217 (2011)
11. Medzhitov, R., Schneider, D. S. &Soares, M. P. Disease tolerance as a defense strategy. Science 335, 936-941 (2012)
12. Iwasaki, A. &Medzhitov, R. Control of adaptive immunity by the innate immune system. Nat. Immunol. 16, 343-353 (2015)
13. Janeway, C. A. Jr &Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197-216 (2002)
14. El-Achkar, T. M. et al. Sepsis induces changes in the expression and distribution of Toll-like receptor 4 in the rat kidney. Am. J. Physiol. Renal Physiol. 290, F1034-F1043 (2006)
15. El Achkar, T. M., Hosein, M. &Dagher, P. C. Pathways of renal injury in systemic gram-negative sepsis. Eur. J. Clin. Invest. 38, 39-44 (2008)
16. Kalakeche, R. et al. Endotoxin uptake by S1 proximal tubular segment causes oxidative stress in the downstream S2 segment. J. Am. Soc. Nephrol. 22, 1505-1516 (2011)
17. Naito, M., Bomsztyk, K. &Zager, R. A. Endotoxin mediates recruitment of RNA polymerase II to target genes in acute renal failure. J. Am. Soc. Nephrol. 19, 1321-1330 (2008)
18. Murugan, R. et al. Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapy. Nephrol. Dial. Transplant. 29, 1854-1864 (2014)
19. Schafer, J. F. Tolerance to plant disease. Annu. Rev. Phytopathol. 9, 235-252 (1971)
20. Larsen, R. et al. A central role for free heme in the pathogenesis of severe sepsis. Sci. Transl Med. 2, 51ra71 (2010)
21. Råberg, L., Sim, D. &Read, A. F. Disentangling genetic variation for resistance and tolerance to infectious diseases in animals. Science 318, 812-814 (2007)
22. Ferreira, A., Balla, J., Jeney, V., Balla, G. &Soares, M. P. A central role for free heme in the pathogenesis of severe malaria: the missing link? J. Mol. Med. 86, 1097-1111 (2008)
23. Hsiao, H. W. et al. The decline of autophagy contributes to proximal tubular dysfunction during sepsis. Shock 37, 289-296 (2012)
24. Bartz, R. R. et al. Staphylococcus aureus sepsis induces early renal mitochondrial DNA repair and mitochondrial biogenesis in mice. PLoS ONE 9, e100912 (2014)
25. Takasu, O. et al. Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am. J. Respir. Crit. Care Med. 187, 509-517 (2013)
26. Hallows, K. R., Mount, P. F., Pastor-Soler, N. M. &Power, D. A. Role of the energy sensor AMP-activated protein kinase in renal physiology and disease. Am. J. Physiol. Renal Physiol. 298, F1067-F1077 (2010)
27. Escobar, D. A. et al. Adenosine monophosphate-activated protein kinase activation protects against sepsis-induced organ injury and inflammation. J. Surg. Res. 194, 262-272 (2015)
28. Howell, G. M. et al. Augmenting autophagy to treat acute kidney injury during endotoxemia in mice. PLoS ONE 8, e69520 (2013)
29. Frauwirth, K. A. et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 16, 769-777 (2002)
30. Vander Heiden, M. G., Cantley, L. C. &Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033 (2009)
31. Smith, J. A., Stallons, L. J. &Schnellmann, R. G. Renal cortical hexokinase and pentose phosphate pathway activation through the EGFR/Akt signaling pathway in endotoxin-induced acute kidney injury. Am. J. Physiol. Renal Physiol. 307, F435-F444 (2014)
32. Waltz, P., Carchman, E., Gomez, H. &Zuckerbraun, B. Sepsis results in an altered renal metabolic and osmolyte profile. J. Surg. Res. 202, 8-12 (2016)
33. Patil, N. K., Parajuli, N., MacMillan-Crow, L. A. &Mayeux, P. R. Inactivation of renal mitochondrial respiratory complexes and manganese superoxide dismutase during sepsis: mitochondria-targeted antioxidant mitigates injury. Am. J. Physiol. Renal Physiol. 306, F734-F743 (2014)
34. Tran, M. et al. PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice. J. Clin. Invest. 121, 4003-4014 (2011)
35. Jin, K. et al. Is acute kidney injury in the early phase of sepsis a sign of metabolic downregulation in tubular epithelial cells? Crit. Care 19 (Suppl. 1), P286 (2015)
36. Faubert, B. et al. AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab. 17, 113-124 (2013)
37. Hudson, C. C. et al. Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin. Mol. Cell. Biol. 22, 7004-7014 (2002)
38. Dodd, K. M., Yang, J., Shen, M. H., Sampson, J. R. &Tee, A. R. mTORC1 drives HIF1α; and VEGFA signalling via multiple mechanisms involving 4EBP1, S6K1 and STAT3. Oncogene 34, 2239-2250 (2014)
39. Cheng, S. C. et al. mTOR-and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345, 1250684 (2014)
40. Yang, L. et al. PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis. Nat. Commun. 5, 4436 (2014)
41. O'Neill, L. A. J. &Hardie, D. G. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 493, 346-355 (2013)
42. Krawczyk, C. M. et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115, 4742-4749 (2010)
43. Jiang, L. &DeBerardinis, R. J. Cancer metabolism: when more is less. Nature 489, 511-512 (2012)
44. Luo, W. et al. Pyruvate kinase M2 is a PHD3 stimulated coactivator for hypoxia-inducible factor 1. Cell 145, 732-744 (2011)
45. Opal, S. et al. Sirt1 activation markedly alters transcription profiles and improves outcome in experimental sepsis. Shock http://dx.doi.org/10.1097/ SHK.0000000000000528 (2015)
46. Vachharajani, V. T. et al. SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome. J. Leukoc. Biol. 96, 785-796 (2014)
47. Gomez, H. et al. A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 41, 3-11 (2014)
48. Patra, K. C. &Hay, N. The pentose phosphate pathway and cancer. Trends Biochem. Sci. 39, 347-354 (2014)
49. Jeon, S-M., Chandel, N. S. &Hay, N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485, 661-665 (2013)
50. Tran, M. T. et al. PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection. Nature 531, 528-532 (2016)
51. Brealey, D. et al. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R491-R497 (2004)
52. Zhou, R., Yazdi, A. S., Menu, P. &Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221-225 (2011)
53. Sayeed, M. M., Zhu, M. &Maitra, S. R. Alterations in cellular calcium and magnesium during circulatory/ septic shock. Magnesium 8, 179-189 (1989)
54. Duchen, M. R., Verkhratsky, A. &Muallem, S. Mitochondria and calcium in health and disease. Cell Calcium 44, 1-5 (2008)
55. Haden, D. W. et al. Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis. Am. J. Respir. Crit. Care Med. 176, 768-777 (2007)
56. Hotchkiss, R. S., Strasser, A., McDunn, J. E. &Swanson, P. E. Cell death. N. Engl. J. Med. 361, 1570-1583 (2009)
57. Carchman, E. H., Rao, J., Loughran, P. A., Rosengart, M. R. &Zuckerbraun, B. S. Heme oxygenase-1 mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice. Hepatology 53, 2053-2062 (2011)
58. Scarpulla, R. C. Metabolic control of mitochondrial biogenesis through the PGC 1 family regulatory network. Biochim. Biophys. Acta 1813, 1269-1278 (2011)
59. Carchman, E. H. et al. Experimental sepsis-induced mitochondrial biogenesis is dependent on autophagy, TLR4, and TLR9 signaling in liver. FASEB J. 27, 4703-4711 (2013)
60. Zager, R. A., Johnson, A. C. M., Hanson, S. Y. &Lund, S. Ischemic proximal tubular injury primes mice to endotoxin-induced TNF-alpha generation and systemic release. Am. J. Physiol. Renal Physiol. 289, F289-F297 (2005)
61. Zager, R. A., Johnson, A. C. M., Hanson, S. Y. &Lund, S. Acute nephrotoxic and obstructive injury primes the kidney to endotoxin-driven cytokine/ chemokine production. Kidney Int. 69, 1181-1188 (2006)
62. Han, S. H. et al. Deletion of Lkb1 in renal tubular epithelial cells leads to CKD by altering metabolism. J. Am. Soc. Nephrol. 27, 439-453 (2016)
63. Liu, T. F., Vachharajani, V. T., Yoza, B. K. &McCall, C. E. NAD+-dependent Sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response. J. Biol. Chem. 287, 25758-25769 (2012)
64. Zhong, L. &Mostoslavsky, R. SIRT6: a master epigenetic gatekeeper of glucose metabolism. Transcription 1, 17-21 (2014)
65. Vega, R. B., Huss, J. M. &Kelly, D. P. The coactivator PGC 1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol. Cell. Biol. 20, 1868-1876 (2000)
66. Lehman, J. J. et al. Peroxisome proliferator-activated receptor gamma coactivator 1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. 106, 847-856 (2000)
67. Kellum, J. A. et al. The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock. Am. J. Respir. Crit. Care Med. 193, 281-287 (2016)
68. Kellum, J. A. et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch. Intern. Med. 167, 1655-1663 (2007)
69. Zager, R. A., Johnson, A. C. M. &Becker, K. Acute unilateral ischemic renal injury induces progressive renal inflammation, lipid accumulation, histone modification, and 'end-stage' kidney disease. Am. J. Physiol. Renal Physiol. 301, F1334-F1345 (2011)
70. Grgic, I. et al. Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int. 82, 172-183 (2012)
71. Heung, M. &Chawla, L. S. Predicting progression to chronic kidney disease after recovery from acute kidney injury. Curr. Opin. Nephrol. Hypertens. 21, 628-634 (2012)
72. Basile, D. P. et al. Progression after AKI: understanding maladaptive repair processes to predict and identify therapeutic treatments. J. Am. Soc. Nephrol. 27, 687-697 (2016)
73. Hodgkins, K. S. &Schnaper, H. W. Tubulointerstitial injury and the progression of chronic kidney disease. Pediatr. Nephrol. 27, 901-909 (2011)
74. Kang, H. M. et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat. Med. 21, 37-46 (2015)
75. Qiu, S. et al. AMPKα2 reduces renal epithelial transdifferentiation and inflammation after injury through interaction with CK2 and beta;. J. Pathol. 237, 330-342 (2015)
76. Bihorac, A. et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am. J. Respir. Crit. Care Med. 189, 932-939 (2014)
77. Kashani, K. et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit. Care 17, R25 (2013)
78. Sharma, A., Mucino, M. J. &Ronco, C. Renal functional reserve and renal recovery after acute kidney injury. Nephron Clin. Pract. 127, 94-100 (2014)
79. Liu, K. D. &Brakeman, P. R. Renal repair and recovery. Crit. Care Med. 36, S187-S192 (2008)
80. Fliser, D., Zeier, M., Nowack, R. &Ritz, E. Renal functional reserve in healthy elderly subjects. J. Am. Soc. Nephrol. 3, 1371-1377 (1993)